FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005666502> ?p ?o ?g. }

• W3005666502 abstract "Abstract Background Previously, we showed that 6β-hydroxytestosterone (6β-OHT), a cytochrome P450 1B1 (CYP1B1)-derived metabolite of testosterone, contributes to angiotensin II (Ang II)-induced hypertension in male mice. This study was conducted to test the hypothesis that 6β-OHT contributes to increased vascular reactivity, endothelial dysfunction, vascular hypertrophy, and reactive oxygen species production associated with Ang II-induced hypertension. Methods Eight- to 10-week-old intact or castrated C57BL/6 J ( Cyp1b1 +/+ and Cyp1b1 −/− ) mice were anesthetized for implantation of a micro-osmotic pump which delivered Ang II (700 ng/kg/day) or saline for 14 days. Mice were injected with 6β-OHT (15 μg/g b.w every third day), flutamide (8 mg/kg every day), or its vehicle. Blood pressure was measured via tail-cuff. Vascular reactivity, endothelial-dependent and endothelial-independent vasodilation, media to lumen ratio, fibrosis by collagen deposition, and reactive oxygen species production by dihydroethidium staining were determined in the isolated thoracic aorta. Results The response of thoracic aorta to phenylephrine and endothelin-1 was increased in Ang II-infused Cyp1b1 +/+ mice compared to intact Cyp1b1 −/− or castrated Cyp1b1 +/+ and Cyp1b1 −/− mice; these effects of Ang II were restored by treatment with 6β-OHT. Ang II infusion caused endothelial dysfunction, as indicated by decreased relaxation of the aorta to acetylcholine in Cyp1b1 +/+ but not Cyp1b1 −/− or castrated Cyp1b1 +/+ and Cyp1b1 −/− mice. 6β-OHT did not alter Ang II-induced endothelial dysfunction in Cyp1b1 +/+ mice but restored it in Cyp1b1 −/− or castrated Cyp1b1 +/+ and Cyp1b1 −/− mice. Ang II infusion increased media to lumen ratio and caused fibrosis and reactive oxygen species production in the aorta of Cyp1b1 +/+ mice. These effects were minimized in the aorta of Cyp1b1 −/− or castrated Cyp1b1 +/+ and Cyp1b1 −/− mice and restored by treatment with 6β-OHT. Treatment with the androgen receptor antagonist flutamide reduced blood pressure and vascular hypertrophy in castrated Ang II-infused mice injected with 6β-OHT. Conclusions 6β-OHT is required for the action of Ang II to increase vascular reactivity and cause endothelial dysfunction, hypertrophy, and increase in oxygen radical production. The effect of 6β-OHT in mediating Ang II-induced hypertension and associated hypertrophy is dependent on the androgen receptor. Therefore, CYP1B1 could serve as a novel target for the development of therapeutics to treat vascular changes in hypertensive males." @default.
• W3005666502 created "2020-02-24" @default.
• W3005666502 creator A5038681571 @default.
• W3005666502 creator A5047026826 @default.
• W3005666502 creator A5055529164 @default.
• W3005666502 creator A5068919298 @default.
• W3005666502 creator A5073932699 @default.
• W3005666502 creator A5080736496 @default.
• W3005666502 date "2020-01-16" @default.
• W3005666502 modified "2023-10-10" @default.
• W3005666502 title "6β-Hydroxytestosterone, a metabolite of testosterone generated by CYP1B1, contributes to vascular changes in angiotensin II-induced hypertension in male mice" @default.
• W3005666502 cites W1976555160 @default.
• W3005666502 cites W1976600568 @default.
• W3005666502 cites W1981256690 @default.
• W3005666502 cites W1993413086 @default.
• W3005666502 cites W2005538723 @default.
• W3005666502 cites W2008478558 @default.
• W3005666502 cites W2030234219 @default.
• W3005666502 cites W2033092950 @default.
• W3005666502 cites W2060160129 @default.
• W3005666502 cites W2063561249 @default.
• W3005666502 cites W2064079848 @default.
• W3005666502 cites W2069930739 @default.
• W3005666502 cites W2095904587 @default.
• W3005666502 cites W2107059714 @default.
• W3005666502 cites W2112944327 @default.
• W3005666502 cites W2113438957 @default.
• W3005666502 cites W2115129960 @default.
• W3005666502 cites W2121438567 @default.
• W3005666502 cites W2124882888 @default.
• W3005666502 cites W2126473502 @default.
• W3005666502 cites W2130399687 @default.
• W3005666502 cites W2130806298 @default.
• W3005666502 cites W2134270369 @default.
• W3005666502 cites W2136483252 @default.
• W3005666502 cites W2145505029 @default.
• W3005666502 cites W2153895826 @default.
• W3005666502 cites W2157509955 @default.
• W3005666502 cites W2286212970 @default.
• W3005666502 cites W2292644001 @default.
• W3005666502 cites W2340829607 @default.
• W3005666502 cites W2416508334 @default.
• W3005666502 cites W2537912946 @default.
• W3005666502 cites W2607378445 @default.
• W3005666502 cites W2972867833 @default.
• W3005666502 doi "https://doi.org/10.1186/s13293-019-0280-4" @default.
• W3005666502 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6966856" @default.
• W3005666502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31948482" @default.
• W3005666502 hasPublicationYear "2020" @default.
• W3005666502 type Work @default.
• W3005666502 sameAs 3005666502 @default.
• W3005666502 citedByCount "12" @default.
• W3005666502 countsByYear W30056665022020 @default.
• W3005666502 countsByYear W30056665022021 @default.
• W3005666502 countsByYear W30056665022022 @default.
• W3005666502 countsByYear W30056665022023 @default.
• W3005666502 crossrefType "journal-article" @default.
• W3005666502 hasAuthorship W3005666502A5038681571 @default.
• W3005666502 hasAuthorship W3005666502A5047026826 @default.
• W3005666502 hasAuthorship W3005666502A5055529164 @default.
• W3005666502 hasAuthorship W3005666502A5068919298 @default.
• W3005666502 hasAuthorship W3005666502A5073932699 @default.
• W3005666502 hasAuthorship W3005666502A5080736496 @default.
• W3005666502 hasBestOaLocation W30056665021 @default.
• W3005666502 hasConcept C120770815 @default.
• W3005666502 hasConcept C126322002 @default.
• W3005666502 hasConcept C134018914 @default.
• W3005666502 hasConcept C155701950 @default.
• W3005666502 hasConcept C185592680 @default.
• W3005666502 hasConcept C2776992346 @default.
• W3005666502 hasConcept C2780972559 @default.
• W3005666502 hasConcept C2908929049 @default.
• W3005666502 hasConcept C526171541 @default.
• W3005666502 hasConcept C62231903 @default.
• W3005666502 hasConcept C71924100 @default.
• W3005666502 hasConcept C84393581 @default.
• W3005666502 hasConceptScore W3005666502C120770815 @default.
• W3005666502 hasConceptScore W3005666502C126322002 @default.
• W3005666502 hasConceptScore W3005666502C134018914 @default.
• W3005666502 hasConceptScore W3005666502C155701950 @default.
• W3005666502 hasConceptScore W3005666502C185592680 @default.
• W3005666502 hasConceptScore W3005666502C2776992346 @default.
• W3005666502 hasConceptScore W3005666502C2780972559 @default.
• W3005666502 hasConceptScore W3005666502C2908929049 @default.
• W3005666502 hasConceptScore W3005666502C526171541 @default.
• W3005666502 hasConceptScore W3005666502C62231903 @default.
• W3005666502 hasConceptScore W3005666502C71924100 @default.
• W3005666502 hasConceptScore W3005666502C84393581 @default.
• W3005666502 hasFunder F4320332511 @default.
• W3005666502 hasIssue "1" @default.
• W3005666502 hasLocation W30056665021 @default.
• W3005666502 hasLocation W30056665022 @default.
• W3005666502 hasLocation W30056665023 @default.
• W3005666502 hasLocation W30056665024 @default.
• W3005666502 hasLocation W30056665025 @default.
• W3005666502 hasOpenAccess W3005666502 @default.
• W3005666502 hasPrimaryLocation W30056665021 @default.
• W3005666502 hasRelatedWork W1991657120 @default.
• W3005666502 hasRelatedWork W1992220075 @default.
• W3005666502 hasRelatedWork W2020571025 @default.

• next